Valuation: PeptiDream Inc.

Market Cap 131B 812M 710M 654M 607M 1.15B 77.02B 1.17B 7.85B 3.05B 38.01B 3.05B 2.98B P/E 2026 *
10.4x
P/E 2027 * 10.5x
Enterprise Value 102B 628M 550M 507M 470M 891M 59.62B 906M 6.08B 2.36B 29.43B 2.36B 2.31B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 1.98x
Free-Float
72.4%
Yield 2026 *
-
Yield 2027 * 0.59%
1 day-2.01%
1 week-3.95%
Current month-3.95%
1 month-0.78%
3 months-18.10%
6 months-41.17%
Current year-38.27%
1 week 1,003.5
Extreme 1003.5
1,069
1 month 916
Extreme 916
1,092
Current year 916
Extreme 916
1,788
1 year 916
Extreme 916
1,818.5
3 years 916
Extreme 916
3,060
5 years 916
Extreme 916
4,950
10 years 916
Extreme 916
6,540
Manager TitleAgeSince
Chief Executive Officer 51 01/01/2022
Chief Operating Officer - 02/07/2026
Chief Tech/Sci/R&D Officer - 01/04/2024
Director TitleAgeSince
Director/Board Member 51 01/08/2008
Director/Board Member 51 01/09/2017
Director/Board Member 55 01/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.01%-3.95%-33.13%-48.49% 828M
-1.53%+0.78%+72.33%+127.47% 57.72B
-2.45%-7.32%+65.23%+83.15% 52.65B
+1.25%+7.10%+19.20%+461.74% 24.46B
-1.82%-1.43%-17.09%-13.83% 23.84B
-3.05%+3.06%+42.36%-5.66% 19.28B
-0.24%+5.11%+38.76%-25.95% 17.8B
+2.34%+14.18%+220.96%+380.99% 17.29B
-6.73%+9.90%+36.04% - 15.28B
-3.01%+3.15%+27.92%+191.87% 14.35B
Average -1.73%+4.48%+47.26%+127.92% 24.35B
Weighted average by Cap. -1.65%+2.69%+57.17%+137.70%

Financials

2026 *2027 *
Net sales 44.71B 276M 242M 223M 206M 392M 26.21B 398M 2.67B 1.04B 12.94B 1.04B 1.01B 46.18B 285M 250M 230M 213M 405M 27.07B 411M 2.76B 1.07B 13.36B 1.07B 1.05B
Net income 12.76B 78.83M 68.99M 63.58M 58.93M 112M 7.48B 114M 762M 296M 3.69B 296M 290M 12.62B 77.92M 68.19M 62.84M 58.25M 111M 7.4B 112M 754M 293M 3.65B 293M 286M
Net Debt -29.67B -183M -160M -148M -137M -260M -17.4B -264M -1.77B -689M -8.59B -688M -673M -40.03B -247M -216M -199M -185M -351M -23.47B -357M -2.39B -930M -11.58B -928M -908M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
745
Date Price Change Volume
08/07/26 ¥1,022.50 -2.01% 836,100
07/07/26 ¥1,043.50 +0.34% 763,100
06/07/26 ¥1,040.00 +1.17% 845,700
03/07/26 ¥1,028.00 -2.05% 873,400
02/07/26 ¥1,049.50 +4.12% 969,900
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,022.50JPY
Average target price
2,825.00JPY
Spread / Average Target
+176.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock